- Research works
- 81 ▲ 67% vs 2013–17
- Citations
- 1.2k 15.1 per fractional work
- Top-10% rate
- 16.3% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: GeneMatrix (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.4×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.4×
- Veterinary 4.2×
- Immunology and Microbiology 3.8×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Medicine 1.4×
- Computer Science 1.4×
- Physics and Astronomy 1.3×
- Agricultural and Biological Sciences 1.0×
- Mathematics 1.0×
- Neuroscience 0.9×
- Economics, Econometrics and Finance 0.7×
- Psychology 0.7×
- Health Professions 0.5×
- Chemistry 0.5×
- Arts and Humanities 0.4×
- Materials Science 0.3×
- Engineering 0.2×
- Environmental Science 0.1×
- Social Sciences 0.0×
Which keywords describe research at GeneMatrix (South Korea)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Targeted Therapy, Cancer Genomics, Mutational Signatures, Inflammation, Gene Expression, Precision Medicine and Corpus Linguistics.
- Precision Medicine
- Gene Expression
- Deep Learning
- Targeted Therapy
- Cancer Genomics
- Cancer
- Mutational Signatures
- Inflammation
- Machine Learning
- Healthcare
- Corpus Linguistics
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 11 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 11 words, with their numbers
- Cancer3▲ 8.2×15 topics
- Cancer Genomics2▲ 113×1 topic
- Mutational Signatures2▲ 113×1 topic
- Targeted Therapy2▲ 38×2 topics
- Inflammation2▲ 3.6×17 topics
- Deep Learning2▲ 1.86×9 topics
- Machine Learning2▲ 1.70×10 topics
- Gene Expression2▲ 8.6×7 topics
- Healthcare1▲ 3.4×4 topics
- Precision Medicine1▲ 7.9×6 topics
- Corpus Linguistics1▲ 16×2 topics
Which research topics does GeneMatrix (South Korea) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Natural Language Processing Techniques, Genetic Associations and Epidemiology and Medical Imaging Techniques and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 2 works
- 2 Natural Language Processing Techniques Artificial Intelligence 1 works
- 3 Genetic Associations and Epidemiology Genetics 1 works
- 4 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 5 Radiation Detection and Scintillator Technologies Radiation 0 works
- 6 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 0 works
- 7 Epigenetics and DNA Methylation Molecular Biology 0 works
- 8 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 9 Virus-based gene therapy research Genetics 0 works
- 10 Liver Disease Diagnosis and Treatment Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GeneMatrix (South Korea)'s research output changed?
Output in 2018–2022 was 67% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seoul
- Seoul National University
- Yonsei University
- Korea University
- Sungkyunkwan University
- Hanyang University
- Kyung Hee University
- Chung-Ang University
- Samsung (South Korea)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.